Harms of Intermittent vs Continuous Androgen-Deprivation Therapy for Prostate Cancer
JAMA Oncol
.
2016 Apr;2(4):461-2.
doi: 10.1001/jamaoncol.2015.4682.
Authors
Saroj Niraula
1
,
Ian F Tannock
2
Affiliations
1
CancerCare Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada.
2
Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
PMID:
26720183
DOI:
10.1001/jamaoncol.2015.4682
No abstract available
Publication types
Comment
MeSH terms
Androgen Antagonists / therapeutic use*
Humans
Male
Prostatic Neoplasms / drug therapy*
Substances
Androgen Antagonists